Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.3740
Nov 13 • 3:59 PM ET Dollar change-0.0184 Percentage change(-4.69%)
Aftermarket Close
0.3708
Aftermarket • 5:00 PM ET Dollar change-0.0032 Percentage change(-0.86%)
Index
-
Market Cap
4.19M
Enterprise Value
4.28M
Income
-3.08M
Sales
20.93M
Book/sh
0.74
Cash/sh
0.19
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
42
IPO
Nov 17, 2017
P/E
-
Forward P/E
-
PEG
-
P/S
0.20
P/B
0.51
P/C
1.98
P/FCF
-
EV/EBITDA
-
EV/Sales
0.20
Quick Ratio
1.37
Current Ratio
2.50
Debt/Eq
0.27
LT Debt/Eq
0.23
Option/Short
No / Yes
EPS (ttm)
-0.31
EPS next Y
-0.19
EPS next Q
-0.09
EPS this Y
69.72%
EPS next Y
42.42%
EPS next 5Y
-
EPS past 3/5Y
86.54% -
Sales past 3/5Y
-18.46% -14.45%
EPS Y/Y TTM
95.01%
Sales Y/Y TTM
10.01%
EPS Q/Q
46.87%
Sales Q/Q
20.56%
Insider Own
10.13%
Insider Trans
0.00%
Inst Own
6.97%
Inst Trans
0.02%
ROA
-25.07%
ROE
-40.33%
ROIC
-28.69%
Gross Margin
52.81%
Oper. Margin
-13.87%
Profit Margin
-14.71%
SMA20
-2.58%
SMA50
-10.46%
SMA200
-41.89%
Trades
Shs Outstand
11.12M
Shs Float
10.07M
52W High
2.56 -85.39%
52W Low
0.33 13.33%
Volatility
7.45% 9.09%
ATR (14)
0.03
RSI (14)
43.86
Beta
2.36
Rel Volume
0.79
Avg Volume
379.50K
Volume
299,170
Perf Week
-10.10%
Perf Month
3.92%
Perf Quarter
-21.26%
Perf Half Y
-51.25%
Perf YTD
-72.30%
Perf Year
-49.32%
Perf 3Y
-93.24%
Perf 5Y
-99.94%
Perf 10Y
-
Prev Close
0.39
Price
0.37
Change %
-4.69%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crosnoe Clark R.10% OwnerDec 17 '25Sale2.32550,7011,276,84217,875Dec 19 09:16 AM
Clark R. Crosnoe, CRC InvestmeStockholderDec 17 '25Proposed Sale2.25986,8512,220,415Dec 17 07:52 PM
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.
CEOMr. T. Ronan Kennedy
Chief Accounting OfficerMr. Bradley Whitford
CSODr. Sibyl Swift Ph.D.
Chief Technology OfficerMr. Zeb Booker
General CounselMr. Lance Blundell